These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 7916401)

  • 1. Contribution of endogenous generation of endothelin-1 to basal vascular tone.
    Haynes WG; Webb DJ
    Lancet; 1994 Sep; 344(8926):852-4. PubMed ID: 7916401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous endothelin generation maintains vascular tone in humans.
    Webb DJ
    J Hum Hypertens; 1995 Jun; 9(6):459-63. PubMed ID: 7473528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic role of endothelin in maintenance of vascular tone in humans.
    Haynes WG; Ferro CE; Webb DJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S183-5. PubMed ID: 8587357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors.
    Love MP; Haynes WG; Gray GA; Webb DJ; McMurray JJ
    Circulation; 1996 Nov; 94(9):2131-7. PubMed ID: 8901663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
    Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
    Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure.
    Hand MF; Haynes WG; Webb DJ
    Kidney Int; 1999 Feb; 55(2):613-20. PubMed ID: 9987085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans.
    Haynes WG; Ferro CJ; O'Kane KP; Somerville D; Lomax CC; Webb DJ
    Circulation; 1996 May; 93(10):1860-70. PubMed ID: 8635265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats.
    McMahon EG; Palomo MA; Brown MA; Bertenshaw SR; Carter JS
    Am J Hypertens; 1993 Aug; 6(8):667-73. PubMed ID: 8217029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.
    Verhaar MC; Strachan FE; Newby DE; Cruden NL; Koomans HA; Rabelink TJ; Webb DJ
    Circulation; 1998 Mar; 97(8):752-6. PubMed ID: 9498538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1-38] in conscious rats.
    Gardiner SM; Compton AM; Kemp PA; Bennett T
    Br J Pharmacol; 1991 Aug; 103(4):2009-15. PubMed ID: 1912989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance.
    Abernethy DR; Laurie N; Andrawis NS
    Clin Pharmacol Ther; 1995 Sep; 58(3):328-34. PubMed ID: 7554707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by phosphoramidon of the regional haemodynamic effects of proendothelin-2 and -3 in conscious rats.
    Gardiner SM; Kemp PA; Bennett T
    Br J Pharmacol; 1992 Oct; 107(2):584-90. PubMed ID: 1422599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vivo effects of endothelin-1 and ETA receptor blockade on arterial, venous and capillary functions in skeletal muscle.
    Ekelund U; Albert U; Edvinsson L; Mellander S
    Acta Physiol Scand; 1993 Jul; 148(3):273-83. PubMed ID: 8213182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regular aerobic exercise reduces endothelin-1-mediated vasoconstrictor tone in overweight and obese adults.
    Dow CA; Stauffer BL; Brunjes DL; Greiner JJ; DeSouza CA
    Exp Physiol; 2017 Sep; 102(9):1133-1142. PubMed ID: 28635124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.
    Ferro CJ; Spratt JC; Haynes WG; Webb DJ
    Circulation; 1998 Jun; 97(23):2323-30. PubMed ID: 9639376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
    Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ
    Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
    Ferro CJ; Strachan FE; Shepherd E; Haynes WG; Webb DJ
    Clin Pharmacol Ther; 2000 Jul; 68(1):67-74. PubMed ID: 10945317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular effects of endothelin-1 in humans and influence of calcium channel blockade.
    Kiowski W; Linder L; Erne P
    J Hypertens Suppl; 1994 Jan; 12(1):S21-6. PubMed ID: 8207561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide.
    Helmy A; Newby DE; Jalan R; Hayes PC; Webb DJ
    Gut; 2003 Mar; 52(3):410-5. PubMed ID: 12584225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men.
    Westby CM; Weil BR; Greiner JJ; Stauffer BL; DeSouza CA
    Clin Sci (Lond); 2011 Jun; 120(11):485-91. PubMed ID: 21143196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.